Condition: Rheumatoid Arthritis · Psoriatic Arthritis · Spondyloarthritis · Sponsor: University Hospital, Toulouse
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
This description comes directly from the study's public registry record.
Adeline RUYSSEN-WITRAND, MD · 561775626 · ruyssen-witrand.a@chu-toulouse.fr
Delphine THUILLEZ · 561776966 · thuillez.d@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Purpan University Hospital | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05039216